Pay in 4 interest-free payments of $108.75 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
thereby reducing the capillary action of the condensed moisture on the sides
Also a DNA synthesis inhibitor in vascular smooth muscle cells
Ralimetinib (LY2228820) is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay
used in the treatment of high blood pressure
R406 Single thereby reducing the capillary actionR406 is a potent Syk inhibitor with IC50 of 41 nM in cell free assays, strongly inhibits Syk but not Lyn, 5 fold less potent to Flt3. Phase 1.
US$ 47.00
US$ 22500.00
US$ 67500.00
US$ 62500.00
US$ 107500.00
US$ 4250.00
US$ 474.50
US$ 56.00
US$ 62500.00
